Neos Therapeutics Company Profile (NASDAQ:NEOS)

About Neos Therapeutics

Neos Therapeutics logoNeos Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform. Its segment is engaged in the development, manufacturing and commercialization of pharmaceuticals. It has utilized its platform to develop its product for the treatment of attention deficit hyperactivity disorder (ADHD). Its product candidates are extended-release (XR), medications in patient-friendly, orally disintegrating tablets (ODT) or liquid suspension dosage forms. Its branded product and product candidates incorporate over two of the prescribed medications for the treatment of ADHD, methylphenidate and amphetamine. Its modified-release drug delivery platform has enabled it to create extended-release ODT and liquid suspension dosage forms of the medications. It focuses on developing Adzenys XR-ODT, Cotempla XR-ODT and NT-0201.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NEOS
  • CUSIP:
Key Metrics:
  • Previous Close: $6.72
  • 50 Day Moving Average: $8.12
  • 200 Day Moving Average: $9.39
  • 52-Week Range: $6.44 - $27.39
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.03
  • P/E Growth: -0.01
  • Market Cap: $106.22M
  • Outstanding Shares: 16,070,000
Additional Links:
Companies Related to Neos Therapeutics:

Analyst Ratings

Consensus Ratings for Neos Therapeutics (NASDAQ:NEOS) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.33 (288.55% upside)

Analysts' Ratings History for Neos Therapeutics (NASDAQ:NEOS)
Show:
DateFirmActionRatingPrice TargetDetails
7/19/2016BMO Capital MarketsReiterated RatingBuy$15.00View Rating Details
5/18/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details
5/17/2016Royal Bank Of CanadaLower Price TargetOutperform$33.00 -> $29.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$33.00 -> $32.00View Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for Neos Therapeutics (NASDAQ:NEOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/1/2016        
8/11/2016Q2($1.16)($1.65)$1.48 million$1.49 millionViewListenView Earnings Details
5/16/2016Q1($0.87)($0.79)ViewListenView Earnings Details
3/17/2016Q4($0.66)($0.57)$1.70 millionViewListenView Earnings Details
9/3/2015Q215($4.31)($7.76)$1.70 million$1.48 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Neos Therapeutics (NASDAQ:NEOS)
Current Year EPS Consensus Estimate: $-5.38 EPS
Next Year EPS Consensus Estimate: $-3.21 EPS

Dividends

Dividend History for Neos Therapeutics (NASDAQ:NEOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neos Therapeutics (NASDAQ:NEOS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/25/2016Richard I EisenstadtCFOBuy3,710$6.82$25,302.20View SEC Filing  
6/13/2016Juergen MartensInsiderBuy10,000$9.90$99,000.00View SEC Filing  
5/19/2016Alan L HellerDirectorBuy10,000$7.61$76,100.00View SEC Filing  
5/19/2016Thomas P McdonnellInsiderBuy3,000$7.56$22,680.00View SEC Filing  
5/18/2016Gregory J RobitailleDirectorBuy7,442$7.55$56,187.10View SEC Filing  
4/20/2016Presidio Partners 2007, L.P.Major ShareholderSell20,367$9.98$203,262.66View SEC Filing  
4/15/2016Presidio Partners 2007, L.P.Major ShareholderSell57,968$10.23$593,012.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Neos Therapeutics (NASDAQ:NEOS)
DateHeadline
finance.yahoo.com logoNeos Therapeutics to Present at the Wells Fargo Securities Healthcare Conference on September 8, 201 … (NASDAQ:NEOS)
finance.yahoo.com - August 31 at 11:23 AM
finance.yahoo.com logoNeos Therapeutics to Present at the Wells Fargo Securities Healthcare Conference on September 8, 2016 (NASDAQ:NEOS)
finance.yahoo.com - August 31 at 11:23 AM
finance.yahoo.com logoNEOS THERAPEUTICS, INC. Financials (NASDAQ:NEOS)
finance.yahoo.com - August 26 at 6:07 PM
live-pr.com logo"Neos Therapeutics, Inc. (NEOS) - Financial and Strategic SWOT Analysis Review" now available at Fast Market Research (NASDAQ:NEOS)
www.live-pr.com - August 26 at 9:26 AM
finance.yahoo.com logoEdited Transcript of NEOS earnings conference call or presentation 11-Aug-16 12:30pm GMT (NASDAQ:NEOS)
finance.yahoo.com - August 19 at 6:21 PM
capitalcube.com logoETF’s with exposure to Neos Therapeutics, Inc. : August 15, 2016 (NASDAQ:NEOS)
www.capitalcube.com - August 15 at 6:41 PM
capitalcube.com logoNeos Therapeutics, Inc. :NEOS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:NEOS)
www.capitalcube.com - August 12 at 6:32 PM
News IconNeos Therapeutics Announces Second Quarter 2016 Financial Results - P&T Community (NASDAQ:NEOS)
www.ptcommunity.com - August 12 at 9:39 AM
biz.yahoo.com logoNEOS THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:NEOS)
biz.yahoo.com - August 12 at 9:39 AM
reuters.com logoBRIEF-Neos Therapeutics Qtrly loss per share $1.65 - Reuters (NASDAQ:NEOS)
www.reuters.com - August 11 at 6:51 PM
finance.yahoo.com logoNeos Therapeutics Announces Second Quarter 2016 Financial Results - Yahoo Finance (NASDAQ:NEOS)
finance.yahoo.com - August 11 at 6:51 PM
finance.yahoo.com logoNeos Therapeutics reports 2Q loss - Yahoo Finance (NASDAQ:NEOS)
finance.yahoo.com - August 11 at 6:51 PM
biz.yahoo.com logoNeos Therapeutics Inc Earnings Call (Q2 2016) (NASDAQ:NEOS)
biz.yahoo.com - August 11 at 9:37 AM
reuters.com logoBRIEF-Neos Therapeutics Qtrly loss per share $1.65 (NASDAQ:NEOS)
www.reuters.com - August 11 at 9:37 AM
sg.finance.yahoo.com logoNeos Therapeutics reports 2Q loss (NASDAQ:NEOS)
sg.finance.yahoo.com - August 11 at 9:37 AM
publicnow.com logoNeos Therapeutics Announces Second Quarter 2016 Financial Results (NASDAQ:NEOS)
www.publicnow.com - August 11 at 9:37 AM
reuters.com logoBRIEF-Neos therapeutics files for mixed shelf of up to $125 million - sec filing - Reuters (NASDAQ:NEOS)
www.reuters.com - August 2 at 11:16 AM
globenewswire.com logoNeos Therapeutics to Host Second Quarter 2016 Financial Results Conference Call on August 11, 2016 - GlobeNewswire (press release) (NASDAQ:NEOS)
globenewswire.com - August 2 at 11:16 AM
publicnow.com logoNeos Therapeutics to Host Second Quarter 2016 Financial Results Conference Call on August 11, 2016 (NASDAQ:NEOS)
www.publicnow.com - August 2 at 11:16 AM
globenewswire.com logoNeos Therapeutics Announces Successful Completion of Bioequivalence Bridging Study for Cotempla XR-ODT ... - GlobeNewswire (press release) (NASDAQ:NEOS)
globenewswire.com - July 30 at 5:48 PM
streetinsider.com logoNeos Therapeutics (NEOS) Reports Successful Completion of Bioequivalence Bridging Study for Cotempla XR-ODT (NASDAQ:NEOS)
www.streetinsider.com - July 29 at 6:34 PM
streetinsider.com logoNeos Therapeutics (NEOS) Reports Successful Completion of Bioequivalence Bridging Study for Cotempla XR-ODT - StreetInsider.com (NASDAQ:NEOS)
www.streetinsider.com - July 29 at 9:26 AM
kcregister.com logoShining on Major News: Neos Therapeutics, Inc. (NASDAQ:NEOS), Angie's List, Inc. (NASDAQ:ANGI), ChannelAdvisor ... - KC Register (NASDAQ:NEOS)
www.kcregister.com - July 28 at 6:38 PM
reuters.com logoBRIEF-Neos Therapeutics Announces Successful Completion of Bioequivalence Bridging Study for Cotempla XR-ODT - Reuters (NASDAQ:NEOS)
www.reuters.com - July 28 at 6:38 PM
biz.yahoo.com logoNEOS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:NEOS)
biz.yahoo.com - July 28 at 4:58 PM
publicnow.com logoNeos Therapeutics Announces Successful Completion of Bioequivalence Bridging Study for Cotempla XR-ODT™ (Methylphenidate Extended-Release Orally Disintegrating Tablet) (NASDAQ:NEOS)
www.publicnow.com - July 28 at 4:18 PM
News IconBack-to-School Tips for Parents of Children with ADHD (NASDAQ:NEOS)
marshfieldmail.com - July 26 at 9:41 AM
News IconChecking in on Stock Volatility for: Neos Therapeutics, Inc. (NASDAQ:NEOS) - Engelwood Daily (NASDAQ:NEOS)
www.engelwooddaily.com - July 22 at 6:17 PM
fiscalstandard.com logoNeos Therapeutics, Inc. (NEOS) Current Analyst Ratings - Fiscal Standard (NASDAQ:NEOS)
www.fiscalstandard.com - July 22 at 6:17 PM
News IconNeos Therapeutics Incorporated (NASDAQ:NEOS) Shorted Shares Increased 32.23% After Market Selling - Consumer Eagle (NASDAQ:NEOS)
www.consumereagle.com - July 22 at 6:17 PM
News IconWhat's Ahead for Neos Therapeutics Inc After Today's Huge Decline? - Press Telegraph (NASDAQ:NEOS)
presstelegraph.com - July 22 at 6:17 PM
News IconToday Neos Therapeutics Inc Stock Rises - Consumer Eagle (NASDAQ:NEOS)
www.consumereagle.com - July 20 at 9:23 AM
ftsenews.co.uk logoNew Broker Ratings For Neos Therapeutics, Inc. (NEOS) - FTSE News (NASDAQ:NEOS)
www.ftsenews.co.uk - July 19 at 9:55 AM
News IconNeos Therapeutics Incorporated (NASDAQ:NEOS) Shorted Shares Decreased By 5.06% - Consumer Eagle (NASDAQ:NEOS)
www.consumereagle.com - July 17 at 5:52 PM
News IconShares Moving Down on the Week: Neos Therapeutics, Inc. (NASDAQ:NEOS) - Engelwood Daily (NASDAQ:NEOS)
www.engelwooddaily.com - July 17 at 5:52 PM
News IconEye on Stock Volatility for: Neos Therapeutics, Inc. (NASDAQ:NEOS) - Engelwood Daily (NASDAQ:NEOS)
www.engelwooddaily.com - July 15 at 11:12 AM
News IconHow Many Neos Therapeutics Inc (NASDAQ:NEOS)'s Analysts Are Bearish? - Press Telegraph (NASDAQ:NEOS)
presstelegraph.com - July 15 at 11:12 AM
News IconNeos Therapeutics Incorporated (NASDAQ:NEOS) Sellers Covered 5.06% of Their Shorts - Consumer Eagle (NASDAQ:NEOS)
www.consumereagle.com - July 13 at 9:21 AM
News IconWhat's Neos Therapeutics Inc Downside After Forming Bearish Double Bottom? - Consumer Eagle (NASDAQ:NEOS)
www.consumereagle.com - July 13 at 9:21 AM
News IconAre Analysts Bullish Neos Therapeutics Inc (NASDAQ:NEOS) After Last Week? - Press Telegraph (NASDAQ:NEOS)
presstelegraph.com - July 8 at 9:19 AM
News IconBMO Capital Initiates Coverage on Neos Therapeutics Inc to Outperform - TheFounders Daily (NASDAQ:NEOS)
www.thefoundersdaily.com - July 6 at 11:01 AM
fiscalstandard.com logoNeos Therapeutics, Inc. (NEOS) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:NEOS)
www.fiscalstandard.com - July 4 at 5:46 PM
News IconUpdate on Stock Volatility for: Neos Therapeutics, Inc. (NASDAQ:NEOS) - Engelwood Daily (NASDAQ:NEOS)
www.engelwooddaily.com - July 2 at 6:05 PM
fiscalstandard.com logoRecently Issued Stock Ratings For Neos Therapeutics, Inc. (NEOS) - Fiscal Standard (NASDAQ:NEOS)
www.fiscalstandard.com - July 2 at 6:05 PM
News IconWatching Stock Volatility for: Neos Therapeutics, Inc. (NASDAQ:NEOS) - Engelwood Daily (NASDAQ:NEOS)
www.engelwooddaily.com - June 29 at 6:17 PM
News IconNeos Therapeutics Incorporated (NASDAQ:NEOS) Short Interest Decreased By 5.06% - Press Telegraph (NASDAQ:NEOS)
presstelegraph.com - June 28 at 11:15 AM
fiscalstandard.com logoNext Weeks Broker Price Targets For Neos Therapeutics, Inc. (NEOS) - Fiscal Standard (NASDAQ:NEOS)
www.fiscalstandard.com - June 28 at 11:15 AM
fiscalstandard.com logoThis Weeks Broker Views For Neos Therapeutics, Inc. (NEOS) - Fiscal Standard (NASDAQ:NEOS)
www.fiscalstandard.com - June 20 at 8:03 AM
4-traders.com logoNEOS THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) (NASDAQ:NEOS)
www.4-traders.com - June 17 at 9:10 AM
biz.yahoo.com logoNEOS THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:NEOS)
biz.yahoo.com - June 16 at 4:07 PM

Social

Neos Therapeutics (NASDAQ:NEOS) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff